Detection of stool DNA mutations before and after treatment of colorectal neoplasia
Sapna Syngal(Brigham and Women's Hospital), Michael W. Ross(University of Minnesota System), Kathleen Morel(Exact Sciences (United States)), Elena M. Stoffel(University of Michigan), David J. Schoetz(Lahey Hospital and Medical Center), Paul C. Schroy(Boston Medical Center), Deepa Jagadeesh(University of Massachusetts Chan Medical School), Daniel C. Chung(Massachusetts General Hospital), Christopher G. Willett
Cited by 49
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932